Question 1

What is NCX 470?

Accepted Answer

NCX 470 is a Other.

Question 2

How often does NCX 470 appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was NCX 470 first tracked by Ergen?

Accepted Answer

First tracked on Jun 18, 2026.

Question 4

When was NCX 470 last mentioned in news?

Accepted Answer

Last active on Jun 18, 2026.

Question 5

What is NCX 470's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is NCX 470 in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving NCX 470?

Accepted Answer

Nicox NCX 470 China Regulatory Feedback (Jun 18, 2026, 7 articles).

Question 8

How did the "Nicox NCX 470 China Regulatory Feedback" event impact NCX 470?

Accepted Answer

NCX 470 is a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure. The positive regulatory feedback in China and anticipated NDA submission in the U.S. are significant steps towards its commercialization.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.